LRIG1在卵巢浆液性囊腺癌细胞对依托泊苷敏感性中的作用研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

叶元,Tel:13517738776

通讯作者:

中图分类号:

基金项目:

桂林市科学研究与技术开发计划项目(No:20130120-3)


Role and mechanism of LRIG1 in SKOV3, siRNALRIG1 KOV3, KOV3/VP16 and siRNALRIG1 KOV3/VP16
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的  探讨亮氨酸重复序列免疫球蛋白样结构域基因-1(LRIG1)在卵巢浆液性囊腺癌(SKOV3)细胞株中对依托泊苷敏感性的可能机制。方法  噻唑蓝比色法(MMT)检测不同浓度VP16干预下48 h的SKOV3细胞组、siRNA LRIG1转染SKOV3细胞组、SKOV3/VP16细胞组和siRNA LRIG1转染SKOV3/VP16细胞组的增殖。平板克隆检测细胞增殖,流式检测细胞凋亡情况,实时荧光定量聚合酶链反应(qRT-PCR)检测LRIG1 mRNA表达。结果  半抑制浓度(IC50)分别为62.90、115.49、156.50和195.42μg/L,siRNA LRIG1转染SKOV3、SKOV3/VP16和siRNA LRIG1转染SKOV3/VP16的耐药指数分别为1.8、2.5和3.1。SKOV3、siRNA LRIG1转染SKOV3、SKOV3/VP16和siRNA LRIG1转染SKOV3/VP16细胞组的克隆率(F =39.338,P =0.000),细胞的LRIG1 mRNA(F =63.095,P =0.000)和凋亡细胞(F =230.046,P =0.000)明显不同,与SKOV3比较,siRNA LRIG1转染SKOV3、SKOV3/VP16和siRNA LRIG1转染SKOV3/VP16细胞的克隆率增加(t =0.026、0.0710和0.125,P =0.042、0.000和0.000),细胞的LRIG1 mRNA降低(t =0.130、0.525和0.825,均P =0.000),凋亡细胞减少(t =
    12.350、35.506和44.412,均P =0.000),与siRNA LRIG1转染SKOV3比较,SKOV3/VP16和siRNA LRIG1转染SKOV3/VP16细胞的克隆率增加(t =0.044和0.099,P =0.001和0.000),LRIG1 mRNA降低(t =0.395和0.695,均P =0.000),凋亡细胞减少(t =23.156和32063,均P <0.05),与SKOV3/VP16比较,siRNA LRIG1转染SKOV3/VP16细胞的克隆率增加(t =0.055,P =0.000),细胞的LRIG1 mRNA降低(t =0.300,P =0.000),凋亡细胞减少(t =8.906,P =0.000)。结论  LRIG1 mRNA影响SKOV3细胞对药物的敏感性,沉默LRIG1的耐药细胞可抑制SKOV3细胞凋亡。

    Abstract:

    Abstract: Objective To investigate the role and possible mechanism of LRIG1 in SKOV3, siRNALRIG1 KOV3, KOV3/VP16 and siRNALRIG1 KOV3/VP16. Methods The cell proliferation of SKOV3, siRNALRIG1 KOV3, KOV3/VP16 and siRNALRIG1 KOV3/VP16 were detected by MMT at different concentrations of VP16, which had been con-cultured for 48 hours. Cell proliferation was detected by plate cloning. Cell apoptosis was detected by flow cytometry. LRIG1 gene expression was detected by quantitative real-time PCR. Results IC50 of SKOV3, siRNALRIG1 KOV3, KOV3/VP16 and siRNALRIG1 KOV3/VP1 were 62.90 μg/L, 115.49 μg/L, 156.50 μg/L and 195.42 μg/L, respectively, with the drug resistance index of 1.8, 2.5 and 3.1 respectively. Compared with SKOV3, the cloning rates had increased (the mean differences were 8.000, 37.692 and 72.000, P < 0.05), the LRIG1 mRNA (the mean differences were 2.994, 88.366 and 279.004, P < 0.05) and apoptotic cells (the mean difference were 48.942, 63.485 83.659, P < 0.05) had decreased significantly in siRNALRIG1 KOV3, SKOV3/VP16 and siRNALRIG1 KOV3/VP16 cells. Compared with siRNALRIG1 KOV3, the cloning rates had increased (the mean differences were 25.000 and 58.824, P < 0.05), the LRIG1 mRNA (the mean differences were 47.478 and 180.147, P < 0.05) and apoptotic cells (the mean differences were 53.678 and 42.687, P < 0.05) had decreased in SKOV3/VP16 and siRNALRIG1 KOV3/VP16 cells (P < 0.05). Compared with SKOV3/VP16, the cloning rates had increased (the mean difference was 10.000, P < 0.05), the LRIG1 mRNA (the mean difference was 92.784, P < 0.05) and apoptotic cells (the mean difference was 37.625, P < 0.05) had decreased in siRNA LRIG1 KOV3/VP16 cells (P < 0.05). Conclusions The LRIG1 gene can affect drug sensitivity of SKOV3 for lower LRIG1 could decrease the apoptosis of cells.

    参考文献
    相似文献
    引证文献
引用本文

阳华,叶元,肖胜军,雷小妹,罗小红. LRIG1在卵巢浆液性囊腺癌细胞对依托泊苷敏感性中的作用研究[J].中国现代医学杂志,2017,(11):1-7

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2016-12-15
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2017-06-15
  • 出版日期:
文章二维码